Mike Lynch
About Mike Lynch
Mike Lynch is an assistant professor at Duke University and the founder of OPX Biotechnologies, Inc., known for his pioneering work in biocatalyst engineering and synthetic metabolic technologies.
Mike Lynch Founder
Mike Lynch is the founder of OPX Biotechnologies, Inc., where he served as Chief Scientific Officer. At OPX Biotechnologies, he played a vital role in the company's development efforts, leading to the successful piloting and demonstration of innovative biotechnological processes. His expertise lies in utilizing engineered biocatalysts for the production of valuable chemicals from renewable resources.
Assistant Professor at Duke University
Mike Lynch is an Assistant Professor in the Biomedical Engineering and Chemistry Departments at Duke University. His academic role involves research and teaching in these specialized fields, contributing to advancements in biotechnology and biochemistry. His work at Duke includes oversight and direction of several significant research initiatives.
Development of 3-Hydroxy Propionic Acid Technology
While at OPX Biotechnologies, Mike Lynch led the development efforts resulting in the successful piloting and demonstration of technology for producing 3-hydroxy propionic acid. This process involved fermentation using engineered biocatalysts to convert sugars into valuable chemicals, showcasing his contributions to biotechnological innovation.
Fatty Acids Production from Sugars
Mike Lynch spearheaded initiatives at OPX Biotechnologies that focused on converting sugars into fatty acids via fermentation. This technology leveraged engineered biocatalysts, demonstrating a sustainable approach to producing these essential compounds.
Synthetic Metabolic Valve Technology
At Duke University, Mike Lynch's team developed the Synthetic Metabolic Valve technology. This innovation enables dynamic metabolic control of microbial metabolism within standardized bioprocesses, representing a significant advancement in the field of biotechnology.